CN101942039A - Parnaparin production method - Google Patents
Parnaparin production method Download PDFInfo
- Publication number
- CN101942039A CN101942039A CN 201010287132 CN201010287132A CN101942039A CN 101942039 A CN101942039 A CN 101942039A CN 201010287132 CN201010287132 CN 201010287132 CN 201010287132 A CN201010287132 A CN 201010287132A CN 101942039 A CN101942039 A CN 101942039A
- Authority
- CN
- China
- Prior art keywords
- concentration
- heparin
- add
- sodium
- dissolved
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229920000669 heparin Polymers 0.000 title claims abstract description 26
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 title claims abstract description 20
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 12
- 229960004762 parnaparin Drugs 0.000 title abstract 4
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims abstract description 22
- 229960002897 heparin Drugs 0.000 claims abstract description 16
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 claims abstract description 6
- ZFGMDIBRIDKWMY-PASTXAENSA-N heparin Chemical compound CC(O)=N[C@@H]1[C@@H](O)[C@H](O)[C@@H](COS(O)(=O)=O)O[C@@H]1O[C@@H]1[C@@H](C(O)=O)O[C@@H](O[C@H]2[C@@H]([C@@H](OS(O)(=O)=O)[C@@H](O[C@@H]3[C@@H](OC(O)[C@H](OS(O)(=O)=O)[C@H]3O)C(O)=O)O[C@@H]2O)CS(O)(=O)=O)[C@H](O)[C@H]1O ZFGMDIBRIDKWMY-PASTXAENSA-N 0.000 claims abstract description 6
- 229960001008 heparin sodium Drugs 0.000 claims abstract description 6
- 235000017281 sodium acetate Nutrition 0.000 claims abstract description 6
- 239000001632 sodium acetate Substances 0.000 claims abstract description 6
- 238000000034 method Methods 0.000 claims abstract description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 4
- 238000004108 freeze drying Methods 0.000 claims abstract description 3
- 229910001385 heavy metal Inorganic materials 0.000 claims abstract description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 16
- 239000000047 product Substances 0.000 claims description 12
- DPDMMXDBJGCCQC-UHFFFAOYSA-N [Na].[Cl] Chemical compound [Na].[Cl] DPDMMXDBJGCCQC-UHFFFAOYSA-N 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 6
- 238000001556 precipitation Methods 0.000 claims description 6
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims description 5
- 238000006243 chemical reaction Methods 0.000 claims description 5
- 230000003647 oxidation Effects 0.000 claims description 4
- 238000007254 oxidation reaction Methods 0.000 claims description 4
- 239000011347 resin Substances 0.000 claims description 4
- 229920005989 resin Polymers 0.000 claims description 4
- YMHOBZXQZVXHBM-UHFFFAOYSA-N 2,5-dimethoxy-4-bromophenethylamine Chemical compound COC1=CC(CCN)=C(OC)C=C1Br YMHOBZXQZVXHBM-UHFFFAOYSA-N 0.000 claims description 3
- 241000545067 Venus Species 0.000 claims description 3
- 230000002378 acidificating effect Effects 0.000 claims description 3
- 239000013078 crystal Substances 0.000 claims description 3
- 230000018044 dehydration Effects 0.000 claims description 3
- 238000006297 dehydration reaction Methods 0.000 claims description 3
- 238000005516 engineering process Methods 0.000 claims description 3
- 239000000706 filtrate Substances 0.000 claims description 3
- 150000002500 ions Chemical class 0.000 claims description 3
- 238000005374 membrane filtration Methods 0.000 claims description 3
- 239000000088 plastic resin Substances 0.000 claims description 3
- 239000008213 purified water Substances 0.000 claims description 3
- 238000004062 sedimentation Methods 0.000 claims description 3
- 150000001298 alcohols Chemical class 0.000 claims description 2
- 230000007935 neutral effect Effects 0.000 claims description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 abstract description 6
- 238000006731 degradation reaction Methods 0.000 abstract description 4
- 239000011780 sodium chloride Substances 0.000 abstract description 3
- 239000003814 drug Substances 0.000 abstract description 2
- 238000002360 preparation method Methods 0.000 abstract description 2
- 239000002253 acid Substances 0.000 abstract 1
- 150000007513 acids Chemical class 0.000 abstract 1
- 150000002302 glucosamines Chemical class 0.000 abstract 1
- 238000009776 industrial production Methods 0.000 abstract 1
- 150000002978 peroxides Chemical class 0.000 abstract 1
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 description 2
- 230000002045 lasting effect Effects 0.000 description 2
- 239000003055 low molecular weight heparin Substances 0.000 description 2
- JPVYNHNXODAKFH-UHFFFAOYSA-N Cu2+ Chemical compound [Cu+2] JPVYNHNXODAKFH-UHFFFAOYSA-N 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000001311 chemical methods and process Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- -1 membrane filtration Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
Images
Landscapes
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010102871329A CN101942039B (en) | 2010-09-16 | 2010-09-16 | Parnaparin production method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010102871329A CN101942039B (en) | 2010-09-16 | 2010-09-16 | Parnaparin production method |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101942039A true CN101942039A (en) | 2011-01-12 |
CN101942039B CN101942039B (en) | 2012-11-28 |
Family
ID=43434262
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2010102871329A Active CN101942039B (en) | 2010-09-16 | 2010-09-16 | Parnaparin production method |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101942039B (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103421128A (en) * | 2013-07-31 | 2013-12-04 | 山东辰中生物制药有限公司 | Method for preparing high-quality low molecular parnaparin sodium |
CN104193848A (en) * | 2014-08-13 | 2014-12-10 | 南京健友生化制药股份有限公司 | Method for removing bacterial endotoxin in heparin sodium |
CN104403025A (en) * | 2014-12-24 | 2015-03-11 | 南京健友生化制药股份有限公司 | Heparin sodium decolorization method |
CN105461830A (en) * | 2016-01-08 | 2016-04-06 | 东营天东制药有限公司 | Method for removing copper ions through poly-chelate resin |
CN109575156A (en) * | 2018-11-05 | 2019-04-05 | 上海宝维医药技术有限公司 | A kind of purification process of low molecular weight heparin |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1990003791A1 (en) * | 1988-10-05 | 1990-04-19 | Nicola Diferrante | Methods for interfering with hiv multiplication and composition for the treatment of aids |
-
2010
- 2010-09-16 CN CN2010102871329A patent/CN101942039B/en active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1990003791A1 (en) * | 1988-10-05 | 1990-04-19 | Nicola Diferrante | Methods for interfering with hiv multiplication and composition for the treatment of aids |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103421128A (en) * | 2013-07-31 | 2013-12-04 | 山东辰中生物制药有限公司 | Method for preparing high-quality low molecular parnaparin sodium |
CN103421128B (en) * | 2013-07-31 | 2015-08-12 | 山东辰中生物制药有限公司 | A kind of preparation method of that heparin of high-quality low-molecular weight handkerchief |
CN104193848A (en) * | 2014-08-13 | 2014-12-10 | 南京健友生化制药股份有限公司 | Method for removing bacterial endotoxin in heparin sodium |
CN104403025A (en) * | 2014-12-24 | 2015-03-11 | 南京健友生化制药股份有限公司 | Heparin sodium decolorization method |
CN105461830A (en) * | 2016-01-08 | 2016-04-06 | 东营天东制药有限公司 | Method for removing copper ions through poly-chelate resin |
CN109575156A (en) * | 2018-11-05 | 2019-04-05 | 上海宝维医药技术有限公司 | A kind of purification process of low molecular weight heparin |
CN109575156B (en) * | 2018-11-05 | 2021-02-23 | 上海宝维医药技术有限公司 | Purification method of low-molecular heparin |
Also Published As
Publication number | Publication date |
---|---|
CN101942039B (en) | 2012-11-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101544999B (en) | Method for producing and purifying high purity and low molecular weight sodium heparin | |
CN101831002B (en) | Preparation method of sodium alginate for tissue engineering | |
CN101942039B (en) | Parnaparin production method | |
CN101550199B (en) | Method for preparing sodium hyaluronate from hyaluronic acid zymotic fluid | |
CN103232558B (en) | Preparation method of high-quality low-molecular weight dalteparin sodium | |
CN105256079A (en) | Purification method for HFCS (high fructose corn syrup) in fructose production process | |
TR201910416T4 (en) | Process for purification of intended glucose polymers for solutions of peritoneal dialysis. | |
CN101633634A (en) | Method for extracting L-proline from fermentation liquor by membrane separation technology | |
CN101434553B (en) | Method for all-film extraction of valine | |
CN115160108B (en) | Process for preparing inositol and phosphoric acid | |
CN106631852A (en) | Method for extracting L-ornithine hydrochloride from L-ornithine fermentation broth | |
CN101492408A (en) | Method for separating tryptophane from fermentation liquor | |
CN103933862A (en) | Membrane method extraction system and membrane method extraction process for alanine production | |
CN103508933A (en) | Separating and purifying method for L-tryptophan | |
CN111574639B (en) | Method for separating and purifying nitraria tangutorum bobr polysaccharide | |
CN104448043A (en) | Method for producing and purifying enoxaparin sodium | |
CN101205258A (en) | Dextran 100 and production technique thereof | |
CN103421128B (en) | A kind of preparation method of that heparin of high-quality low-molecular weight handkerchief | |
CN105440163A (en) | Method for preparing and purifying enoxaparin sodium | |
CN101205257A (en) | Dextran 10 and production technique thereof | |
CN102276742A (en) | Method for cleanly producing MMW (medium molecular weight) hydroxyethyl starches | |
CN102584611B (en) | Production method for medical grade valine | |
CN102276751B (en) | Method for extracting glycosaminoglycan from bullacta exarata | |
CN102372788A (en) | Mactra veneriformis glycosaminoglycan extraction method | |
CN102432495B (en) | Method for separating and concentrating L-theanine from glutaminase or glutamyl transpeptidase conversion liquid by membrane integration technology |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: DONGYING TIANDONG BIOCHEMICAL INDUSTRY CO., LTD. |
|
C41 | Transfer of patent application or patent right or utility model | ||
C53 | Correction of patent of invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Yang Xiaohong Inventor after: Zhang Zaizhong Inventor after: Guo Lin Inventor after: Li Rong Inventor after: Wang Chunmei Inventor after: Liu Wei Inventor after: Zhang Yanyan Inventor after: Yu Hexin Inventor before: Liu Wei Inventor before: Zhang Yanyan Inventor before: Yu Hexin |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: LIU WEI ZHANG YANYAN YU HEXIN TO: YANG XIAOHONG ZHANG ZAIZHONG GUO LIN LI RONG WANG CHUNMEI LIU WEI ZHANG YANYAN YU HEXIN |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20110927 Address after: 257000 Shandong District of Dongying city in Dongying Province North Road No. 726 in the building Applicant after: SHANDONG HI-TECH CHEMICAL GROUP Co.,Ltd. Co-applicant after: DONGYING TIANDONG BIOCHEMICAL INDUSTRY Co.,Ltd. Address before: 257000 Shandong District of Dongying city in Dongying Province North Road No. 726 in the building Applicant before: SHANDONG HI-TECH CHEMICAL GROUP Co.,Ltd. |
|
ASS | Succession or assignment of patent right |
Owner name: DONGYING TIANDONG PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: DONGYING TIANDONG BIOCHEMICAL INDUSTRY CO., LTD. Effective date: 20120914 |
|
C41 | Transfer of patent application or patent right or utility model | ||
C53 | Correction of patent of invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Guo Lin Inventor after: Li Rong Inventor after: Cui Huifei Inventor before: Yang Xiaohong Inventor before: Zhang Zaizhong Inventor before: Guo Lin Inventor before: Li Rong Inventor before: Wang Chunmei Inventor before: Liu Wei Inventor before: Zhang Yanyan Inventor before: Yu Hexin |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: YANG XIAOHONG ZHANG ZAIZHONG GUO LIN LI RONG WANG CHUNMEI LIU WEI ZHANG YANYAN YU HEXIN TO: GUO LIN LI RONG CUI HUIFEI |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20120914 Address after: 257000 Shandong District of Dongying city in Dongying Province North Road No. 726 in the building Applicant after: SHANDONG HI-TECH CHEMICAL GROUP Co.,Ltd. Applicant after: DONGYING TIANDONG PHARMACEUTICAL Co.,Ltd. Address before: 257000 Shandong District of Dongying city in Dongying Province North Road No. 726 in the building Applicant before: SHANDONG HI-TECH CHEMICAL GROUP Co.,Ltd. Applicant before: DONGYING TIANDONG BIOCHEMICAL INDUSTRY Co.,Ltd. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CP03 | Change of name, title or address |
Address after: 257000 West of HaoChun Road, Dongying District, Dongying City, Shandong Province Co-patentee after: DONGYING TIANDONG PHARMACEUTICAL Co.,Ltd. Patentee after: Shandong Haike Chemical Co.,Ltd. Address before: 257000 Shandong District of Dongying city in Dongying Province North Road No. 726 in the building Co-patentee before: DONGYING TIANDONG PHARMACEUTICAL Co.,Ltd. Patentee before: SHANDONG HI-TECH CHEMICAL GROUP Co.,Ltd. |
|
CP03 | Change of name, title or address | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20200506 Address after: 257000 No. two, 1236 South Road, Dongying District, Shandong, Dongying Patentee after: DONGYING TIANDONG PHARMACEUTICAL Co.,Ltd. Address before: 257000 West of HaoChun Road, Dongying District, Dongying City, Shandong Province Co-patentee before: DONGYING TIANDONG PHARMACEUTICAL Co.,Ltd. Patentee before: Shandong Haike Chemical Co.,Ltd. |